The Textbook of Nanoneuroscience and Nanoneurosurgery
Nanoneuroscience, nanoneurosurgery, and nanobioelectronics have revolutionized medicine and improved the prevention, diagnosis, and treatment of neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing curre...
Đã lưu trong:
| Tác giả của công ty: | |
|---|---|
| Tác giả khác: | , , , |
| Định dạng: | Điện tử eBook |
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2024.
|
| Phiên bản: | 2nd ed. 2024. |
| Những chủ đề: | |
| Truy cập trực tuyến: | https://doi.org/10.1007/978-3-030-80662-0 |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-030-80662-0 | ||
| 003 | DE-He213 | ||
| 005 | 20260907145337.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 241113s2024 sz | o |||| 0|eng d | ||
| 020 | |a 9783030806620 |9 978-3-030-80662-0 | ||
| 024 | 7 | |a 10.1007/978-3-030-80662-0 |2 doi | |
| 050 | 4 | |a RC346-429.2 | |
| 072 | 7 | |a MJN |2 bicssc | |
| 072 | 7 | |a MED056000 |2 bisacsh | |
| 072 | 7 | |a MKJ |2 thema | |
| 082 | 0 | 4 | |a 616.8 |2 23 |
| 245 | 1 | 4 | |a The Textbook of Nanoneuroscience and Nanoneurosurgery |h [electronic resource] / |c edited by Babak Kateb, John D. Heiss, John S. Yu, Ming Hsieh. |
| 250 | |a 2nd ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 online resource (XVI, 849 p. 285 illus.). |b 221 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of colour is Not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background colour |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All Non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a From Nanotechnology to Nanoneuroscience/Nanoneurosurgery and Nanobioelectronics: A review of Milestones -- Nanoneurology and Nanoneurosurgery -- Nanopolymers and Nanoconjugates for Central Nervous System Theranostics -- Micelles and Liposomes: Lipid Nano-vehicles for Intracerebral Drug Delivery -- Peptide and Protein-Based Nanoparticles -- Endohedral Metallofullerenes, Iron Oxide Agents, and Gold Nanoparticles for Brain Imaging -- Carbon Nanoplatforms and Theranostics for Neurological Disorders -- Dendrimers -- Ligand-Based Targeting of therapeutics and Imaging Agents for Cancer -- Nano-assisted immune-Based Targeting in Cancer -- Directed Drug Convection Using Magnetic Nanoparticles as Therapeutic Carriers: Meeting the Challenge of Specific Brain Pharmacotherapeutics, Non-Ligand-Based Central Nervous System Targeting, Including Magnetic Focusing -- Intralesional and Intraparenchymal Convection-Enhanced Delivery of Nanoparticles -- Therapeutics delivery across the blood-brain barrier -- Nanomedicine Treatment Strategies That Exploit Unique Characteristics of Tumor Vasculature and Microenvironment -- Application of nanoplatforms Focused Ultrasounds Neuromodulation -- Nanosensors -- Implantable Infusion Pumps incorporating nanotechnology -- Application of Nanoplatforms for Intracerebral Neurotransmitter Recording -- State-of-art therapy for Neuronopathic Lysosomal Storage Diseases -- Nanotechnology for Cerebral Aneurysm Treatment -- Improving Treatment of Stroke through Nanotechnology -- Molecular Medical Devices for Nanoneurosurgery -- Nanoneuroscience for Epilepsy Management -- Application of Nanotechnology to Disease of Spine -- Nanoparticle-based Treatment and Imaging of Brain Tumors: Potential and Limitations -- Tumor-Targeted Nanodrugs for Treatment of Primary Brain Tumors -- Application of Nanotechnology in Diagnosis and Treatment of Brain metastasis -- Nanotechnology in Extra-Axial and Pituitary Tumors -- Using Nanoparticles in Diagnosis and Treatment of CNS infection -- Application of Nanotechnology in Movement Disorder -- Nanomedicine in Demyelinating Disease: Application to Diagnosis and Therapey in Multiple Sclerosis -- Application of Nanotechnology in Degenerative Disorders of the Brain -- Brain-Machine Interface and Rehabilitation -- Nanobioelectronics for non-invasive neural therapy -- In Vitro and In Vivo Techniques to Assess Neurotoxicity of Nanoparticles -- Nanorobotics for Neurosurgery -- Imaging and Tracking Therapeutic Cells with Nanoparticles -- Micro and Nanotechnology in Nerve Repair -- Nanotechnology: Applications to Pediatric Neurosurgery -- Food and Drug Administration Regulatory Framework for Nanodrugs and Nanodevices and the Combination -- Key policies issues and initiatives related to Nanoneurosurgery and Nanoneuroscience -- Application of Nanotechnology for Neurovascular Disorders -- Nanoneurosurgery and Radiotherapy -- Inorganic nano-systems for Nanoneuroscience -- Nanobioelectronics: Neuro-ophthalmology and Artificial Retina -- Application of a Conceptual Nanomedical Platform to Facilitate the Mapping of the Human Brain: Survey of Cognitive Functions and Implications -- Clinical trials in nanomedicine -- Nanostructured Boron and Gadolinium Compounds for BNCT (Boron-Neutron Capture Therapy) -- The use of microfluidic-based systems in Nanoneuroscience -- Application of 3D (bio)printing in Nanoneuroscience -- Brain Mapping in Glioma patients: from improvement of Clinical outcomes to critical implications in fundamental Neuroscience -- Nanomedicine and Genetherapy -- Nanoneuroscience for COVID19 Brain -- Application of Crisper and nanotechnology for Neurological Disorders -- NASA/National Labs Nanotechnology -- Acute Brain Injuries and Nanotechnology. | |
| 520 | |a Nanoneuroscience, nanoneurosurgery, and nanobioelectronics have revolutionized medicine and improved the prevention, diagnosis, and treatment of neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing current information about nanoplatforms and their use in neurosurgery, neurology, neuroscience, and neuroradiology. The text also reviews the latest regulatory guidelines that influence the translation of nanotechnological research from the laboratory to the clinic, as well as the most recent information on biodevices and pharmaceutical spinoffs. It highlights presidential and congressional initiatives and programs that may significantly impact the field in the near future. Chapters discuss the latest science and technologies―which are applied to diagnosis and treatment of neurological disorders―as well as regulatory issues that impact product development. This volume describes advances that have already been translated to the clinic or hold significant promise for future application in nanoneurosurgery, as well as their potential impact. A full-color text, the book contains contributions by more than 120 researchers, original and descriptive illustrations, and more than 3,000 references. Offering broad coverage of nanotechnological applications in diverse areas and addressing FDA regulation and healthcare policy,The Textbook of Nanoneuroscience and Nanoneurosurgery provides a foundation of ideas and methods for scientists and physicians to devise successful, less invasive procedures for future treatment of nervous system disorders. | ||
| 532 | 8 | |a Accessibility summary: This PDF does Not fully comply with PDF/UA standards but does include limited screen reader support, descriptions for Non-text content (such as images and graphs), bookmarks for easy navigation, and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognise the importance of accessibility and welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility | |
| 532 | 8 | |a Inaccessible, or known limited accessibility | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Neurology . | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Toxicology. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 1 | 4 | |a Neurology. |
| 650 | 2 | 4 | |a Pharmaceutics. |
| 650 | 2 | 4 | |a Neuroscience. |
| 650 | 2 | 4 | |a Toxicology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 700 | 1 | |a Kateb, Babak. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Heiss, John D. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Yu, John S. |e editor. |0 (orcid)0000-0001-9024-2182 |1 https://orcid.org/0000-0001-9024-2182 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Hsieh, Ming. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783030806613 |
| 776 | 0 | 8 | |i Printed edition: |z 9783030806637 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031551925 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-030-80662-0 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||